CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organisations and companies.

Applications for the 2026 CSL Research Acceleration Initiative are now closed.

If you have a partnering opportunity that you would like to share with CSL, we encourage you do so via our Open Innovation Submission Portal.